phoneCall Now for a Free Case Evaluation - 800-611-7080

Yaz Lawsuit and Yasmin Lawsuit Settlements Update

Yaz Lawsuit Update

Yaz Lawsuit Update

Bayer’s pockets opened wider for more Yaz Lawsuit and Yasmin Lawsuit settlements. Bayer began offering to pay Yaz settlements and Yasmin Lawsuit  settlements in 2012.  To date, Yaz Lawsuit cases have been focused on serious blood clot injuries including some claims of blood clot related Yaz deaths.  Today Thompson Reuters News and Insights reported Bayer has agreed to Yaz lawsuit settlements involving gallbladder injuries and/or gallbladder disease. The caveats, like the drug, may make for additional potentially nasty Yaz side effects.

Bayer has agreed to pay over a billion dollars for Yaz lawsuit settlements involving blood clot injuries. Yaz settlements for blood clots have averaged over $200,000.00 and are taken on contingency with the Yaz lawyer getting paid only if/after the case is won or settles. For women suffering possible Yaz gallbladder injury reportedly, the agreed upon amounts are much, much less.

A Yaz lawsuit is taken on contingency meaning potential victims of Yaz blood clot injury have access to a Yaz lawyer and to the justice system without needing to pay money up front. A Yaz lawyer must use and risk their own resources to pursue a claim. Many Yaz lawsuit cases claiming blood clot injury have already resulted in a significant Yaz settlement. Women that have suffered Yaz blood clots are urged to seek the advice of a Yaz lawyer but that may not turn out to be the case for suffers of potential gallbladder injury.

Bayer’s agreement to entertain Yaz settlements for gallbladder injury is fraught with potential difficulty for women that did not have a potential Yaz blood clot but instead had their gallbladder removed say some Yaz lawyers.

Bayer, reportedly citing lack of evidence Yaz or Yasmin cause gallbladder injury, Bayer placed significant caps on the settlements. The total amount allotted, say’s the article in Reuters, is 24 million, a much lower number than that set aside for Yaz lawsuit cases for Yaz potential Yaz blood clot injury. It has been estimated that gallbladder settlements will range between $2000 and $3000 dollars, depending on degree of injury and number of cases filed.

Bayer reportedly offered to the latest in Yaz settlement agreements to avoid litigation but continues to deny any culpability for any injuries alleged in Yaz lawsuit cases. The bottom-line literally, is yes, Bayer has now agreed to pay Yaz settlements for gallbladder injury but will the potential victims have difficulty finding a pathway to payment? Fortunately, women that may have suffered potentially deadly Yaz blood clot injury have more potential for hope of possible financial compensation.

http://www.nlm.nih.gov/medlineplus/gallbladderdiseases.html

 

 

 

Yasmin and Yaz Lawsuit Settlement Amounts Update

Yaz Lawsuit Settlements Update

Yaz Lawsuit Settlements Update

Bayer to pay over a billion dollars in Yaz lawsuit settlements and Yasmin lawsuit settlements reports Reuters. On March 4, 2013 Thompson Reuters News & Insights published an article written by Terry Baynes  said “Bayer AG set aside over $1.5 billion in 2012 to cover litigation expenses tied to its Yasmin and Yaz oral contraceptives”.  Women that may have been injured may be entitled to a Yaz settlement but should seek help from a Yaz Lawyer and may need to file a Yaz lawsuit.

Bayer recently issued their most recent Stockholder Quarterly Report for third quarter 2012. The report details out gains, losses (including Yaz settlements concerns) and future growth for all segments of the corporation. Yaz and Yasmin fall in the Pharmaceuticals sub group of their healthcare division. According to their latest Stockholder report, healthcare comprises 45.8% of their sales with pharmaceuticals accounting for 26.6% of that. Clearly, the pharmaceutical industry is a very good business niche to be in if they can set aside over a billion dollars for Yaz settlements and still project growth and profit.

Yaz Class Action Lawsuit Information

Yaz lawsuits are not limited to the US say reports. The article published by Thompson Reuters states that Bayer is facing 13 class actions lawsuits in Canada and are expecting more Yaz lawsuits and Yasmin lawsuits to be filed in the US.

The US legal system is slightly different than in Canada. In the US there are no Yaz call action lawsuits. The Yaz lawsuits filed in the US have been grouped together as a multidistrict litigation. In a Yaz class action lawsuit the litigants would not retain their individual status as they do in a multidistrict litigation.

Yaz Lawsuit Commercial Marketing Claims Have Had no Effect

As we have reported in the past, Bayer does not appear to have any intention of slowing down their marketing efforts on Yaz. In the most recent Stockholders report (3rd Qtr 2013) shows a slight decline if Yaz and Yasmin sales but the popular drug still remains among their best-selling pharmaceuticals. Bayer blames sales of the generic equivalent of Yaz/Yasmin for the decline in market share seen by the two medications. Even though some Yaz lawsuits claim death may have been caused by Yaz and Yasmin, Bayer is reporting a projected growth in sales in North America and emerging markets including China and Russia.

Women interested in learning more about Yaz lawsuit settlements should speak with an experienced Yaz lawyer.

 

Yaz Lawsuit Settlements References:

http://newsandinsight.thomsonreuters.com/Legal/News/2013/03_-_March/Bayer_reserves_$1_5_bln_to_cover_Yasmin,_Yaz_lawsuits/

Yaz Lawsuit Settlements to Continue in 2013

Yaz Lawsuit Settlements 2013

Yaz Lawsuit Settlements 2013

Bayer tells their stockholders to expect more Yaz lawsuit settlements  in 2013. Bayer now committed to spending millions settling Yaz lawsuits focuses on keeping stockholders happy with a strong bottom-line. The possibility of paying millions of dollars to potential victims in Yaz lawsuit claims does not however slow Bayer’s push to promote the product. Despite reports of deaths, women worldwide continue to buy Yaz and Yasmin making it one of the bestselling pharmaceuticals for the German manufacturer.

Is Bayer remorseful or just plain resourceful?  Clinical data presented during Yaz lawsuit discovery as well as post marketing studies of the drospirenone containing oral contraceptives Yaz, Yasmin and Ocella suggest the potential of an increased risk of blood clot injury is present for women taking the drug. Bayer, in a brilliant move to contain any potential damage to their bottom-line announces Yaz settlements but offers no mea culpa.

Bayer’s Annual Report for their fiscal year 2012 is beautifully prepared. The art work as well as the content suggest global power and success but if read closely, includes  interesting information for anyone with concerns about healthcare for women not only here at home but globally.

Any woman that has faced the need to prevent an unwanted pregnancy will tell you it may not be a choice. She may hate the idea of swallowing a birth control pill. However, preventing pregnancy may be an economic necessity for her family. It is also a billion dollar industry for drug manufacturers. In the face of necessity versus greed; who wins in the end? Ask any Yaz lawyer that has a client whose wife or mother died from a blood clot injury if obtaining a Yaz lawsuit made up for the lost life.

Emerging markets or exploitation?  Bayer’s annual report for 2012 says “But sales from our Pharmaceuticals segment rose nonetheless, thanks to new products and continuing growth momentum in emerging markets.” The reports also says “Our largest segment in terms of sales – Pharmaceuticals– aims to become a leader in cardiovascular health and continue to expand the leading position it already holds in women’s healthcare.”

The term “emerging markets” was coined in 1981 and has come to mean different things to different people in business or economic terms. In general, everyone agrees that an emerging market is any country developing the ability to sustain and grow their economy. Typically, the per capita income is very low by US and Western European standards. Approval to market a drug more easily obtained so is less costly for the manufacture. Regulations for marketing and sales are less restrictive than in the US.

 

Women’s healthcare tends to remain under-developed in emerging markets. Personal injury may be taken less seriously. If that is true then of even more interest and concern is the question of “What happens if a woman in emerging markets such as India or China sustains a blood clot injury while taking Yaz, what will she do?”  Will she be able to obtain a Yaz lawyer or file a Yaz lawsuit? Will she be entitled to a Yaz settlement and if so, how much (or little) will it cost Bayer?   Will there ever be a Yaz recall? What is exploitation? You decide.

 

References

http://www.annualreport2012.bayer.com/en/bayer-annual-report-2012.pdfx

 

 

 

Yaz Lawsuit cases filed due to amputations and other blood clot injuries

Yaz Lawsuit Due to Side Effects

Yaz Lawsuit Due to Side Effects

02/25/2013  Yaz Lawsuit Update on Amputations and other injuries due to Yaz Side Effects: Yaz blood clots may lead to amputation say Yaz Lawsuit News reports. The effects of a thrombolytic event can be devastating. In some instances, a blood clot in a deep vein (DVT) could result in amputation of that limb. It has been reported that a 37 year old wife and mother living in Oklahoma, filed a Yaz lawsuit claiming she developed a Yaz blood clot and had an emergency amputation of her arm.

Reports abound of studies linking Yaz to potentially serious blood clots including DVTs and pulmonary embolism (PE). The ultimate, potentially deadly effects of blood clots on the body include heart attack and stroke. A pulmonary embolism, depending on severity can mean taking medications including blood thinners for the remainder of a potentially shortened lifespan. One side effect of a DVT that is not often mentioned is the real possibility of amputation.

A vascular Web article explains phlegmasia cerulea dolens, a rare form of DVT and the potential for amputation if it occurs. “Phlegmasia cerulea dolens, if not adequately treated, can cause gangrene, which is tissue death and occurs when tissues in your body do not receive enough oxygen and blood. Gangrene is very serious and can lead to amputation.”

Yaz Lawsuit Settlements and Amounts

In 2012 Bayer began the Yaz lawsuit settlements process but have not admitted wrong doing. In fact, the products remain on the market and continue to be promoted by Bayer. There has been no Yaz recall but there does not have to be a Yaz or Yasmin recall to file a Yaz lawsuit or potentially be entitled to a Yaz lawsuit settlement if you have suffered injury potentially related to the drugs. Reported Yaz Lawsuit Settlement amounts currently range in the two hundred thousand to two hundred and fifty thousand dollar range on average. This is an average, some Yaz Lawsuit Settlements  could exceed one million dollars.

Yaz Lawsuit and Commerical Marketing

Yaz is a birth control pill that at one time was marketed heavily by Bayer Pharmaceuticals as a treatment for premenstrual dysphoric disorder (PMDD) and acne. The claims made by Bayer about Yaz and Yasmin made the two oral contraceptives very popular among women. Later, Bayer was accused of over-stating the effectiveness of the birth control for treatment of PMDD.

The national Institutes of Health describe PMDD: “Premenstrual dysphoric disorder (PMDD) is a condition in which a woman has severe depression symptoms, irritability, and tension before menstruation. The symptoms of PMDD are more severe than those seen with premenstrual syndrome (PMS)” Allegedly, Yaz and Yasmin are more effective for PMS than for PMDD.

Women that have taken Yaz or Yasmin for any of the approved reasons and suffered a potentially serious blood clot while taking Yaz may be entitled to file a Yaz lawsuit and may be entitled to a Yaz settlement. However; for some women, time may be running out due to certain State and Federal regulations governing the amount of time allowed during which a Yaz lawsuit can be filed. Only a knowledge Yaz lawyer can fully explain your options.

 

Citations

http://www.vascularweb.org/vascularhealth/pages/deep-vein-thrombosis-%28-dvt-%29-.aspxhttp://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0004461/

Yaz Lawsuit Settlements Made Without Admitting Wrongdoing

Yaz Lawsuit Case Settlements

Yaz Lawsuit Case Settlements

02/15/2013   As Bayer Continues to offer Yaz Lawsuit Settlements to the thousands of Yaz Lawsuit Plaintiffs, there is an interesting aspect in these offers. Although Bayer has announced to its stockholders that it will spend almost one billion dollars to settle Yas and Yasmin Lawsuits, Bayer denies any wrongdoing in the case.  It has been reported that Yaz Lawsuit Settlement offers come with the stipulation that Bayer does not admit that they have done anything wrong.

Even as more Yaz Lawsuit cases are filed, Bayer continues to offer significant Yaz Lawsuit Settlement Amounts to rid itself of the existing cases it faces.  It seems somewhat disingenuous to claim that a company has done nothing wrong, yet offer to pay hundreds of millions of dollars to settle lawsuits that claim  they have in fact engaged in wrongdoing.

Although lawsuit settlements like those being offered in the Yaz Lawsuit often come with the stipulation that the defendant is not admitting to wrongdoing but instead is “buying peace”, in the case of the Yaz Lawsuit, this claim seems odd.  To settle a single lawsuit to “buy peace” because a defendant would rather not deal with the rigors of facing the lawsuit is sometimes understandable. To pay hundreds of millions of dollars to thousands of defendants just to “buy peace” does not make sense.

Of course, plaintiffs are likely to agree to the denial of wrongdoing stipulation. Ultimately, it is in the interest of Vaginal Mesh Lawsuit plaintiffs to settle their cases so that they can receive compensation for their injuries. Mounting Medical Bills, lost work and other damages and expenses suffered by those injured by Yaz have been financially devastating for many Yaz Lawsuit plaintiffs and their families. Agreeing to the stipulation that Bayer admits no wrongdoing may be a small price to pay to receive the compensation so desperately needed by many of those injured by Yaz.

 

 

 

Yaz Lawsuit News and Info

Yaz Lawsuit News Release

Yaz Lawsuit News Release

02/13/2013 Bayer announces reports increase in Yaz and Yasmin sales while announcing Yaz Lawsuit Settlements. In a move typical of a major pharmaceutical manufacturer, Bayer agreed to Yaz lawsuit settlements that may total about 750 million in the US but refuses to admit wrongdoing, instead pushing forward with the sales of the popular oral contraceptives.

Yaz Lawsuits number in the Thousands

 

Bayer discloses information about Yaz lawsuit settlements and Yasmin lawsuit settlements in their Stockholder’s Newsletter covering their financial report for the period ending September 30, 2012. The same newsletter announces the news that their oral contraceptives, Yaz and Yasmin while the subject of over 13000 Yaz lawsuits and Yasmin lawsuits remains among Bayer’s top selling pharmaceuticals.

Bayer’s disclosure to stockholders says “Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and / or YAZ™ or from the use of Ocella™ and / or Gianvi™, generic versions of Yasmin™ and YAZ™, respectively, marketed by Barr Laboratories, Inc. in the United States. As of October 15, 2012, Bayer had reached agreements, without admission of liability, to settle the claims of about 3,490 claimants in the U.S. for a total amount of about US$750 million.”

 

Yaz lawyers contend their clients have been seriously harmed by the extremely popular combined hormonal contraceptives (CHC).  For any Yaz lawyer that has filed a Yaz lawsuit on behalf of an individual that died while taking Yaz, the news that Bayer is continuing move forward with Yaz settlements is positive but the idea that the product remains a top producer for Bayer may make any Yaz lawyer’s successes bittersweet.

 

 Yaz Side Effects Leading to Lawsuits

 

Are potentially deadly Yaz side effects and Yaz lawsuits just a blip on the radar for Bayer? Bayer’s financial report for the period ending September 30, 2012 acknowledges the allegations made by claimants in Yaz lawsuits and Yasmin Lawsuits include the allegations they “suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products” but the report announces Yaz and Yasmin sales worldwide increased by 0.07% for the same financial period in 2011.

 

Yaz Recall Unlikely

 

Has there been a Yaz recall? There has not been a Yaz recall nor does it seem likely there will be. In fact, the manufacturer seems intent on further promotion of the oral contraceptives that may have been linked to so many serious injuries and reportedly is looking to emerging markets such as China as their next target rich environment for sales.

 

Will Yaz lawsuit settlements have a negative impact on the manufacturer? Individuals that were potentially injured by Yaz or Yasmin may endure long term, expensive inpatient care. Typically, a pulmonary embolism, heart attack or stroke (some of the reported side effects possibly associated with the use of Yaz), will require admission to an intensive care unit (ICU). Depending on the type of insurance coverage and the length of the stay in ICU a woman may be faced with a hospital bill she can’t pay. Follow-up care could be ongoing leaving the potential victim to struggle with ever increasing, possibly insurmountable medical expenses. Medical debt can impact credit scores and quality of life.

 

Bayer meanwhile, even after announcing hefty Yaz settlements, has a healthy credit report, according to their Stockholder newsletter. Says Bayer’s report “Standard & Poor’s gives Bayer a long-term issuer rating of A- with positive outlook, while Moody’s gives us a long-term rating of A3 with stable outlook. The short-term ratings are A-2 (Standard & Poor’s) and P-2 (Moody’s). These investment-grade ratings document good creditworthiness.”

 

Is justice served? Injury can’t be undone. Death is the ultimate finality. Both injury and death are among the allegations made by potential victims that filed Yaz lawsuits.  Potential victims that sought the help of a Yaz lawyer and filed a Yaz lawsuit may be entitled to financial compensation. Perhaps a positive outcome will offer solace to those suffering potentially irreparable harm.

 

 

 

 

 

 

Yazmin Lawsuit and Yaz Lawsuit Settlements Progressing Slowly

Yaz Lawsuit and Yasmin Lawsuit Update

Yaz Lawsuit and Yasmin Lawsuit Update

02/08/2013  Although Bayer Pharmaceuticals is continuing to meet with lawyers to settle Yasmin Lawsuits and Yaz Lawsuits, the progress is much slower than many Yaz and Yasmin injury victims hope for. Even as Bayer settle Yasmin Lawsuit and Yaz Lawsuits, more Yaz and Yasmin Lawsuits continue to be filed.

Yasmin Lawsuit Settlement Amounts

Both Yasmin  and Yaz Lawsuit Settlement amounts continue to reported as averaging over two hundred thousand dollars. Whether this amount continues to remain accurate is yet to be seen.  We have received reports that Bayer has only came to settlement agreements with between 5% and 10 % of the Yaz and Yasmin Lawsuit Plaintiffs that have already filed lawsuits.

It is not possible to get an accurate number of the number of Yaz Lawsuits and Yasmin Lawsuits that have been settled as most settlements in cases like this are confidential. Information on the number of Yaz and Yasmin Lawsuits that have been settled comes from sources that cannot be verified.

Yaz and Yasmin Class Action Lawsuit

The Yas and Yasmin Class Action Lawsuit, or Multidistrict Litigation as it is more properly called continues. The Federal Court proceeding which consolidates a large number of the Yaz and Yasmin Lawsuits outstanding, is not likely be terminated until Bayer has reached settlements with all of the plaintiffs in the case.

Some plaintiffs that have filed Yaz Lawsuits and Yasmin Lawsuits, may not elect to accept settlement offers from Bayer. In these cases a trial will be necessary. Bayer’s efforts to settle these cases would indicate that Bayer would like to avoid trials if possible. The expense of thousands of trials would be enormous and it is in the interest of Bayer to avoid defending a large number of lawsuits at trial if possible.

Yasmin and Yaz Side Effects Victims Continue to Wait

As Bayer undertakes the process of sitting down with lawyers representing those injured by Yaz and Yasmin, these individuals continue to bear the weight of the expenses and other damages they suffered due to these birth control products.

Yasmin and Yaz lawsuit can still be filed.  There is a time limit for filing a Yaz Lawsuit or Yasmin Lawsuit however, many of those injured still have time to file a Yaz or Yasmin Lawsuit.

Yaz Lawsuit Update on Accuracy of Yaz Lawsuit Settlement Amounts

Yaz Lawsuit News Release

Yaz Lawsuit News Release

01/25/2013  Yaz Lawsuit  Update on Accuracy of Yaz Lawsuit Settlement Amounts: A variety of reports have been made about the Average Yaz Lawsuit settlement amounts.  Yaz Lawsuit settlement reports have indicated that the Average Yaz Lawsuit settlement amount is between  two hundred and two hundred and fifty thousand dollars. The broad range of average Yaz Lawsuit settlement amounts have many confused. Ultimately the current reports on Yaz Lawsuit Settlement amounts may bear little resemblance to the final average settlement amount for Yaz Lawsuits once all cases have been settled.

Yaz Lawsuit Settlement Amounts

The reason the Yaz Lawsuit Average Settlement amounts may ultimately be far different from what is currently being reported is a result of two basic reasons.  The first reason is that no all women who are eligible to file a Yaz Lawsuit have done so as of yet.  It is unknown and unknowable how many women that were injured by Yaz have yet to file suit. There will come a time when the time limit to file a Yaz Lawsuit has expired and at that point and only at that point, will it be known how many Yaz Lawsuit cases will ultimately be filed against Bayer.

The second reason that the current Yaz Lawsuit average settlement amounts may not be accurate is due to the fact that it appears that Bayer may be taking longer to settle cases that will result in the largest payouts.  This could be simply because these are more complex cases however, there may be another reason Bayer is delaying the settlement of cases that will result in large payouts. Bayer is owned by its stockholders and its stock is traded on the stock exchange.  Massive lawsuits like the Yaz Case can negatively impact a stock price.  The top executives at Bayer are required to keep their stock holders informed regarding anything that could have a significant negative impact on the company.  By delaying settlement of the Yaz cases that will result in the largest payouts, the average Yaz Lawsuit Settlement Amount remains lower than it would be if the larger potential settlements were included in the average.  If Bayer is able to delay the settlement of the cases that will result in the largest payouts until the time they can announce that the Yaz Lawsuit is essentially behind them, then the positive effect the news of the end of the Yaz Lawsuit could outweigh the negative news of any increase in the reported average Yaz Lawsuit Settlement.  There is no way to know if Bayer is taking these factors into consideration in determining the order in which they settle Yaz cases, however from the stand point of protecting their stock price, the possibility exists.

Now is the Time to File Your Yaz Lawsuit

If you were injured by Yaz, now is the time to retain legal counsel and file your case.  Waiting to file you Yaz Lawsuit could result in it being dismissed because of time limits. If you were injured by Yaz and have yet to file your Yaz Lawsuit, contact the hotline number on this page and get the process started immediately to receive compensation for your injuries.

Reource Links

http://www.seedol.com/blog/2012/12/28/yaz-lawsuit-settlement-amounts-from-yaz-birth-control-lawsuits-965

http://www.jbenj.com/yaz-lawsuit-information-and-news-63499

 

 

Yaz Birth Control Lawsuit Information Update

Yaz Birth Control Lawsuit

Yaz Birth Control Lawsuit

12/21/2012 Yaz Birth Control Lawsuit:  After reviewing the most recent stock holder report from Bayer, we found very little mention of the effect that Yaz Lawsuit settlements have had or will have on the company. Although Bayer has already paid out a significant amount of money to settle Yaz Lawsuits, the company paid a healthy dividend to investors and the overall profitability of Bayer does not seem to have been effected to any great extent. More Yaz Lawsuits are still being filed. If you were among those who suffered a blood clot related injury while taking Yaz, contact us today to arrange a free consultation with a Yaz Lawyer.

Yaz Lawsuit Settlement Reports

Bayer announced that it would be settling Yaz Lawsuits earlier this year in a news release directed at stock holders and stock analyst.  Bayer has periodically released other information about the average cost of settling Yaz Lawsuit has been to date, although the information has not been comprehensive and of course is not final.

Yaz Lawsuit Cases are still being filed

There are still a large number of Yaz Lawsuits outstanding and more Yaz Lawsuit cases continue to be filed. Although Bayer’s decision to settle Yaz Lawsuits is most likely in the best interest of Bayer Stockholders, those injured by Yaz still have to live with the consequences of  Bayer’s  defective product. It is to Bayer’s credit that they are settling Yaz Lawsuit cases without forcing those who have been injured by Yaz to endure a trial and wait to be compensated for their injuries.

Yaz Class Action Lawsuit

The Yaz Multidistrict Litigation, often referred to as the Yaz Class Action Lawsuit is still ongoing. The decision on the part of Bayer to offer Yaz Lawsuit settlements did not stop the Yaz Lawsuit Multidistrict Litigation ongoing in Federal Court. Any individual lawsuit is not likely to be dismissed by the plaintiffs until a settlement is actually reached with Bayer. The process of settling the massive volume of Yaz Lawsuits Bayer currently faces is no small task and it will take time for lawyers working for Bayer to sit down with each Law Firm representing those injured by Yaz to go over their case filed and settle their cases.

How Yaz Lawsuit Settlement Amounts are determined

Although the specifics of how Bayer determines what to offer in settlement on any given Yaz Lawsuit is proprietary information, there is a general method for mass settlement efforts such as the one ongoing the Yaz Lawsuit. Generally a settlement matrix is developed. The settlement matrix will take numerous factors into consideration.  Some of the factors that will be considered are the amount of medical bills a plaintiff has incurred as a result of their injuries, lost wages as well as future potential expenses related to the injuries sustained by the plaintiffs.  Most of the factors stem from the extent of the injury suffered by the plaintiff.

 

Yaz and Yasmin Lawsuit Settlements Continue

Yaz Lawsuit and Yasmin Lawsuit Settlements

Yaz Lawsuit and Yasmin Lawsuit Settlements

12/14/2012  Yaz Lawsuit and Yasmin Lawsuit Settlement news  Bayer has released a new product Xarelto, to the market with FDA approval for expanded use to treat or reduce the risks of blood clots associated with Yaz, Yazmin and Ocella. The 4th generation birth control pills manufactured by Bayer have been linked to increased risks of potentially deadly blood clots.  Xarelto may offer a degree of safety but is not going to solve the problems for all women potentially injured or possible killed by a serious thromboembolic event. Following on the heels of the release of Xarelto comes the even more encouraging news that Bayer continues with Yaz lawsuit settlements of both ongoing Yaz lawsuits as well as suits Yaz Lawyers are no doubt, continuing to file.

The most recent release of financial information claims an estimated 3500 cases have been settled so far. For women living with devastation caused by a blood clot to the deep veins, lungs, heart and brain, this news of continued Yaz settlements strikes a note of justice and hope in their hearts.   Reports indicate Yaz settlements tend to fall in the $250000.00 range but some cases involving more serious injuries or death may reach well into the millions. Scientific studies linking Yaz, a 4th generation birth control pill, to an increased risk of blood clots may have been a factor in Bayer’s decision to settle cases.  Information received indicates the first round of cases to be settled will be those involving less serious injuries. Cases involving more serious injury or death require and deserve additional attention when discussing a potential Yaz settlement.

In another bit of hopeful news, Yaz Lawsuit settlements may now begin to include cases filed on behalf of  women that took Bayer’s generic product, Ocella. Unless your doctor specifies “brand only” when writing a prescription, a pharmacist can substitute a generic without asking your permission. For this reason, some women believed they had been taking Yaz when their injury occurred only to discover they had been taking Ocella. The Supreme Court ruled that manufacturers of generic medications can’t be included in cases like a Yaz Lawsuit. When news of Yaz related blood clot injuries first became public knowledge, women were told they most likely would not be eligible for a Yaz lawsuit settlement leaving them with little or no hope of any compensation for their injuries. Despite this ruling, Bayer is settling Ocella Lawsuits along with Yaz Lawsuits and Yasmin Lawsuits.